Case Report: Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase

By Lainas TG   Sfontouris IA   Zorzovilis IZ   Petsas GK   Lainas GT   Alexopoulou E   Kolibianakis EM  

Reproductive BioMedicine Online, Vol. 19, Iss. 6, 2009-12 ,pp. : 789-795

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS

By Aboulghar Mohamed A   Mansour Ragaa T   Amin Yahia M   Al-Inany Hesham G   Aboulghar Mona M   Serour Gamal I  

Reproductive BioMedicine Online, Vol. 15, Iss. 3, 2007-09 ,pp. : 271-279

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol

By Humaidan P   Bungum L   Bungum M   Hald F   Agerholm I   Blaabjerg J   Andersen C Yding   Lindenberg S  

Reproductive BioMedicine Online, Vol. 11, Iss. 6, 2005-12 ,pp. : 679-684

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles - a prospective, randomized study

By Vlaisavljevic Veljko   Reljic Milan   Lovrec Vida Gavric   Kovacic Borut  

Reproductive BioMedicine Online, Vol. 7, Iss. 3, 2003-10 ,pp. : 301-308

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist

By Garcia-Velasco JA   Coelingh Bennink HJT   Epifanio R   Escudero E   Pellicer A   Simón C  

Reproductive BioMedicine Online, Vol. 15, Iss. 3, 2007-09 ,pp. : 280-287

Reproductive Healthcare Ltd

Access to resources Recommend Favorite